This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Phoenix sees EU review of McKesson deal extended following French referral request

By Andrew Boyce ( February 25, 2022, 14:58 GMT | Insight) -- German pharmaceutical wholesaler Phoenix could face French scrutiny of its plan to buy US rival McKesson’s operations in France and other European countries. The Autorité de la Concurrence filed a request this week asking the European Commission to hand over the national part of the review, MLex has learned.German pharmaceutical wholesaler Phoenix could face French scrutiny of its plan to buy US rival McKesson’s operations in France and other European countries....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections